REGULATION OF CHOLANGIOCYTE PROLIFERATION BY THE miR-125B/HDC/HA/VEGF AXIS IN THE MDR2-/- MOUSE MODEL OF PRIMARY SCLEROSING CHOLANGITIS

被引：0
|
作者：
Han, Y. [1 ]
Meng, F. [2 ]
Hargrove, L. [1 ]
Graf, A. [2 ]
Kennedy, L. [2 ]
Francis, H. [1 ,2 ]
机构：
[1] Scott & White Healthcare & Texas A&M Hlth Sci Ctr, Temple, TX USA
[2] Cent Texas Vet Hlth Care Syst, Temple, TX USA
来源：
JOURNAL OF HEPATOLOGY | 2014年 / 60卷 / 01期
关键词：
D O I：
10.1016/S0168-8278(14)60510-9
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P348
引用
收藏
页码：S183 / S183
页数：1
相关论文
共 50 条
  • [31] Glucagon like Peptide (GLP)-2 Treatment Improves Liver and Bile Duct Injury in the Mdr2-/- Mouse Model of Sclerosing Cholangitis
    Menz, Moritz
    Hinterleitner, Lorenz
    Koenigshofer, Philipp
    Halilbasic, Emina
    Kunczer, Victoria
    Stojakovic, Tatjana
    Reiberger, Thomas
    Fuchs, Claudia Daniela
    Trauner, Michael H.
    HEPATOLOGY, 2018, 68 : 831A - 831A
  • [32] Administration of Serotonin Receptor 2A/2B/2C Antagonists Decreases Ductular Reaction and Hepatic Fibrosis in the Mdr2-/- Mouse Model of Primary Sclerosing Cholangitis (PSC).
    Kyritsi, Konstantina
    O'Brien, April
    White, Tori
    Chen, Lixian
    Meng, Fanyin
    Venter, Juliet
    Wu, Nan
    Zhou, Tianhao
    Alpini, Gianfranco
    Glaser, Shannon S.
    HEPATOLOGY, 2018, 68 : 131A - 131A
  • [33] A New Mdr2-/- Mouse Model of Sclerosing Cholangitis with Rapid Fibrosis Progression, Early-Onset Portal Hypertension, and Liver Cancer
    Ikenaga, Naoki
    Liu, Susan B.
    Sverdlov, Deanna Y.
    Yoshida, Shuhei
    Nasser, Imad
    Ke, Qingen
    Kang, Peter M.
    Popov, Yury
    AMERICAN JOURNAL OF PATHOLOGY, 2015, 185 (02): : 325 - 334
  • [34] Human Placental Mesenchymal Stem Cells Relieve Primary Sclerosing Cholangitis via Upregulation of TGR5 in Mdr2-/- Mice and Human Intrahepatic Cholangiocyte Organoid Models
    Yao, Qigu
    Chen, Wenyi
    Yu, Yingduo
    Gao, Feiqiong
    Zhou, Jiahang
    Wu, Jian
    Pan, Qiaoling
    Yang, Jinfeng
    Zhou, Lingling
    Yu, Jiong
    Cao, Hongcui
    Li, Lanjuan
    RESEARCH, 2023, 6
  • [35] Tetrahydroxylated bile acids improve cholestatic liver and bile duct injury in the Mdr2-/- mouse model of sclerosing cholangitis via immunomodulatory effects
    Fuchs, Claudia D.
    Dixon, Emmanuel D.
    Hendrikx, Tim
    Mlitz, Veronika
    Wahlstrom, Annika
    Stahlman, Marcus
    Scharnagl, Hubert
    Stojakovic, Tatjana
    Binder, Christoph J.
    Marschall, Hanns-Ulrich
    Trauner, Michael
    HEPATOLOGY COMMUNICATIONS, 2022, 6 (09) : 2368 - 2378
  • [36] Prolonged darkness reduces liver fibrosis in a mouse model of primary sclerosing cholangitis by miR-200b down-regulation
    Wu, Nan
    Meng, Fanyin
    Zhou, Tianhao
    Han, Yuyan
    Kennedy, Lindsey
    Venter, Julie
    Francis, Heather
    DeMorrow, Sharon
    Onori, Paolo
    Invernizzi, Pietro
    Bernuzzi, Francesca
    Mancinelli, Romina
    Gaudio, Eugenio
    Franchitto, Antonio
    Glaser, Shannon
    Alpini, Gianfranco
    FASEB JOURNAL, 2017, 31 (10): : 4305 - 4324
  • [37] Inhibition of H2 histamine receptor by Vivo-Morpholino treatment decreases mast cell activation, large biliary proliferation, angiogenesis, fibrosis and inflammation in the Mdr2-/- mouse model of primary sclerosing cholangitis
    Kennedy, Lindsey
    Demieville, Jennifer
    Hargrove, Laura
    Meng, Fanyin
    Alpini, Gianfranco
    Smith, Steven
    Francis, Heather L.
    HEPATOLOGY, 2017, 66 : 110A - 110A
  • [38] INHIBITION OF TRANSFORMING GROWTH FACTOR BETA 1 (TGFβ1) BY VIVO-MORPHOLINO (VM) AMELIORATES CHOLESTASIS IN THE MDR2-/- MOUSE MODEL OF PRIMARY SCLEROSING CHOLANGITIS (PSC)
    Chen, Lixian
    Zhou, Tianhao
    Kundu, Debjyoti
    Meadows, Vik
    Kennedy, Lindsey
    Kyritsi, Konstantina
    Wu, Nan
    Meyer, Alison A.
    Owen, Travis M.
    Alpini, Gianfranco
    Francis, Heather L.
    GASTROENTEROLOGY, 2022, 162 (07) : S1216 - S1216
  • [39] COMBINATION TREATMENTS OF AN IBAT INHIBITOR AND VARIOUS PPAR ISOFORM AGONISTS INDUCE DISTINCT CHANGES IN LIVER BIOCHEMISTRIES IN THE MDR2-/-MOUSE MODEL OF SCLEROSING CHOLANGITIS
    Kudira, Ramesh
    Pfuhler, Liva
    Mullen, Mary
    Whyte, Senyo
    Bariya, Priya
    Zhang, Wujuan
    Setchell, Kenneth D. R.
    Kostrub, Cory
    Vig, Pamela
    Miethke, Alexander
    HEPATOLOGY, 2022, 76 : S1509 - S1509
  • [40] Original Article MiR-125b targeted regulation of MKNK2 inhibits multiple myeloma proliferation and invasion
    Tan, Binbin
    Yang, Gaohui
    Su, Liangyan
    Zhou, Jicheng
    Wu, Yinying
    Liang, Chunfeng
    Lai, Yongrong
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2024, 16 (07): : 3366 - 3375
12345